Today: 7 February 2026
Subscribe

Applied Materials Stock (AMAT) News Today: Analyst Targets Rise on AI Chip Demand, Even as China Export Curbs Loom

Applied Materials Stock (AMAT) News Today: Analyst Targets Rise on AI Chip Demand, Even as China Export Curbs Loom

Dec. 20, 2025 — Applied Materials, Inc. (NASDAQ: AMAT) is ending the week near recent highs after a volatile stretch that featured a fresh 52‑week peak, heavy trading volume, and a steady drumbeat of analyst updates tied to the AI-led semiconductor buildout. The latest U.S. session (Friday, Dec. 19, 2025) saw Applied Materials stock close at $256.41, up 1.15% on the day. That close leaves AMAT about 7% below its 52‑week high of $276.10, set on Dec. 10, and it came with volume around 25.3 million shares, well above the stock’s recent average. MarketWatch For investors watching AMAT stock into
20 December 2025
··
Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics (EWTX) Stock: Latest News, Analyst Forecasts, and What’s Driving the December 2025 Surge

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) is ending mid-December 2025 in classic clinical-stage biotech fashion: big percentage swings, a sharp momentum breakout, and investors trying to decide whether the move is “new information” or simply “new positioning.” As of Saturday, December 20, 2025, EWTX is being widely quoted around $25.55—a level reached after a powerful jump in the prior U.S. session. StockAnalysis+1 What matters for readers tracking the stock isn’t just the price print. It’s the why: a late-stage neuromuscular story (sevasemten), a closely watched cardiovascular program (EDG-7500), and a pipeline that can re-rate quickly on clinical updates—up or down. PR
20 December 2025
···
Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research (LRCX) Stock News Today: Record High, Analyst Upgrades to $200, and 2026 Outlook (Dec. 20, 2025)

Lam Research Corporation (NASDAQ: LRCX) is ending the week on a sharp upswing after a volatile December stretch—and the latest headlines on December 20, 2025 point to a clear driver: a cluster of analyst upgrades and price-target hikes tied to strengthening AI- and memory-led semiconductor spending expectations. With U.S. markets closed on Saturday, the most recent tape investors are working from is Friday, Dec. 19, when Lam Research stock closed at $172.27 (+4.60%), after trading as high as $173.58 on unusually heavy volume. Investing.com+1 Below is a comprehensive roundup of the current news, forecasts, and analyses circulating on 20.12.2025, plus
20 December 2025
·····
Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco (CSCO) Stock News, Analyst Forecasts, and 2026 Outlook: What Investors Are Watching on Dec. 20, 2025

Cisco Systems, Inc. (NASDAQ: CSCO) is closing out December with renewed attention from Wall Street after a milestone rally that pushed the networking giant back above its dot-com era peak. Shares ended the latest session (Friday, Dec. 19) at $78.42, up 1.91% on the day, after trading between $76.79 and $79.17 with heavy volume. Yahoo Finance+1 The move keeps Cisco within striking distance of the recent record close near $80.25—a level that effectively marked a “full circle” moment for long-time shareholders after more than two decades. Financial Times+1 But the bigger story for investors isn’t just the chart (and it
20 December 2025
····
CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave Stock (CRWV) Surges on DOE Genesis Mission and Citi Buy Call: News, Forecasts, and 2026 Risks (Dec. 20, 2025)

CoreWeave, Inc. (NASDAQ: CRWV) has snapped back sharply after a bruising second half of 2025, with the AI infrastructure stock jumping about 22.5% in the latest session to around $83, after trading between roughly $70.70 and $84.19 on heavy volume. The move caps a week dominated by two storylines investors keep circling: validation (government and Wall Street endorsements) versus vulnerability (debt, dilution risk, and execution bottlenecks). Here’s what’s driving CoreWeave stock right now—and what matters most heading into 2026. Why CoreWeave stock jumped: Citi’s “Buy” (with a warning label) and the DOE Genesis Mission Citi resumes coverage: bullish rating, lower
20 December 2025
·····
Seagate Technology (STX) Stock Today (Dec. 20, 2025): Nasdaq-100 Catalyst, AI Storage Demand, Dividend, and Wall Street Forecasts

Seagate Technology (STX) Stock Today (Dec. 20, 2025): Nasdaq-100 Catalyst, AI Storage Demand, Dividend, and Wall Street Forecasts

Seagate Technology Holdings plc (NASDAQ: STX) enters the final full week of 2025 with momentum—and a looming index catalyst that could reshape near-term trading. As of Dec. 20, 2025, STX is quoted around $296 after a volatile run that pushed the stock near fresh highs earlier this month. The stock’s 2025 rally has been powered by a powerful theme: AI-driven data creation is forcing hyperscalers and cloud platforms to build more storage capacity, and Seagate is positioning itself as a key beneficiary through its high-capacity nearline hard drives and the ramp of its Mozaic HAMR (heat-assisted magnetic recording) platform. Seagate’s
20 December 2025
·····
Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

Amicus Therapeutics Stock (FOLD) Surges as BioMarin Agrees to Buy the Rare-Disease Biotech for $4.8 Billion

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) is suddenly trading like a classic merger-arbitrage stock after BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire the company in an all-cash deal valued at roughly $4.8 billion. BioMarin’s offer of $14.50 per share sparked a sharp re-pricing of Amicus shares, which have been hovering just below the bid as investors weigh deal timing, closing risk, and what the buyout means for Amicus’ two commercial rare-disease franchises—Galafold (Fabry disease) and Pombiliti + Opfolda (Pompe disease). SEC+1 Below is a detailed breakdown of the latest news (as of 20.12.2025), plus the most relevant
20 December 2025
·····
DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

DJT Stock News Today: Trump Media & Technology Group Jumps on $6B TAE Fusion Merger—Price, Forecasts, and Key Risks (Dec. 20, 2025)

Dec. 20, 2025 — Trump Media & Technology Group Corp. (NASDAQ: DJT) is back in the spotlight after announcing a surprise all-stock merger with nuclear fusion company TAE Technologies—a deal the companies describe as valued at more than $6 billion and aimed at accelerating the buildout of a utility-scale fusion power plant. GlobeNewswire+1 The announcement sparked a sharp rally in DJT stock, which surged more than 40% on Dec. 18 and remained highly active as traders repositioned around what many see as a dramatic pivot: from a money-losing social media business to a long-dated, high-uncertainty bet on the future of
20 December 2025
····
Netflix Stock (NFLX) News Today: Warner Bros. Deal Drama, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

Netflix Stock (NFLX) News Today: Warner Bros. Deal Drama, Analyst Forecasts, and What to Watch Next (Dec. 20, 2025)

Netflix, Inc. (NASDAQ: NFLX) stock is ending the week near $94 per share after the U.S. market close on Friday, Dec. 19, with trading activity now heavily shaped by one headline: Netflix’s proposed $72 billion acquisition of Warner Bros. Discovery’s studios and streaming assets—and the bidding war and regulatory scrutiny swirling around it. Investing.com+1 With markets closed on Saturday, Dec. 20, investors are using the weekend to digest a fast-moving mix of merger updates, fresh analyst target changes, and Netflix’s latest strategic pushes into gaming and real-world experiences. Reuters+2The Verge+2 Netflix stock price: where NFLX stands heading into the weekend
20 December 2025
·······
Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Stock (NASDAQ: FLY) News Today — Dec. 20, 2025: Why Shares Jumped, Analyst Forecasts, SEC Filings, and the Lawsuit Clock

Firefly Aerospace Inc. (NASDAQ: FLY) is back in the spotlight as of Saturday, December 20, 2025—not because markets are open today (they aren’t), but because Friday’s session (Dec. 19) delivered the kind of price action that turns a newly public space company into weekend reading. FLY stock surged 22.82% on Dec. 19 to close at $24.65, after climbing 8.31% the day before. StockAnalysis+1 That two-day jump is now colliding with a dense stack of “investor attention catalysts”: a fresh analyst initiation, updated Wall Street price targets, a resale registration tied to the SciTec acquisition, and a still-active securities lawsuit timeline.
20 December 2025
····
Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA, Inc. (NYSE: FIX) heads into the final full week of 2025 with two headline catalysts in focus: a year-end leadership transition and a pending move into the S&P 500—both of which are shaping weekend headlines, analyst commentary, and positioning ahead of Monday’s open. As of the most recently available quote tied to the last U.S. trading session (Friday, Dec. 19, 2025), FIX traded around $940.74, up roughly 2.36% on the day. MarketScreener What’s driving Comfort Systems USA stock on Dec. 20, 2025 1) Comfort Systems confirms leadership changes effective at year-end Late Friday, the company announced a
20 December 2025
···
JPMorgan Chase Stock (JPM) Forecast and News on Dec. 20, 2025: Expense Outlook, Fed Cuts, Buybacks, and Crypto Tokenization

JPMorgan Chase Stock (JPM) Forecast and News on Dec. 20, 2025: Expense Outlook, Fed Cuts, Buybacks, and Crypto Tokenization

Updated: Saturday, December 20, 2025 (markets last closed Friday) JPMorgan Chase & Co. (NYSE: JPM) heads into the weekend near recent highs after a choppy December that reminded investors of a familiar JPMorgan story: the “fortress balance sheet” can keep delivering, but the market will still punish any sign that costs are rising faster than confidence. Shares last closed at $317.21 on Friday, Dec. 19, up 1.35% on the day, as the broader market also posted solid gains. The Wall Street Journal+1 Now, with JPMorgan’s Q4 and full-year 2025 earnings set for Tuesday, Jan. 13, 2026 (results around 7:00 a.m.
20 December 2025
·····
1 … 1,370 1,371 1,372 1,373 1,374 … 2,708

Stock Market Today

Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop